Chemoinformaics analysis of GIBBERELLIN A63
| Molecular Weight | 348.395 | nRot | 1 |
| Heavy Atom Molecular Weight | 324.203 | nRig | 24 |
| Exact Molecular Weight | 348.157 | nRing | 5 |
| Solubility: LogS | -3.612 | nHRing | 1 |
| Solubility: LogP | 0.682 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 52.545 |
| nHD | 3 | BPOL | 27.549 |
| QED | 0.484 |
| Synth | 6.534 |
| Natural Product Likeliness | 3.561 |
| NR-PPAR-gamma | 0.795 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.247 |
| HIA | 0.773 |
| CACO-2 | -5.843 |
| MDCK | 0.000430369 |
| BBB | 0.579 |
| PPB | 0.460805 |
| VDSS | 0.583 |
| FU | 0.52515 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.324 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.412 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.265 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.147 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.032 |
| CL | 4.13 |
| T12 | 0.083 |
| hERG | 0.017 |
| Ames | 0.011 |
| ROA | 0.792 |
| SkinSen | 0.019 |
| Carcinogencity | 0.615 |
| EI | 0.018 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.573137 |